M.L. Richard Yip
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Natural product bioactivities and synthesis 3
- Protein Tyrosine Phosphatases 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 5
- Chemokine receptors and signaling 2
- Co-authors
- Nicholas J. Lawrence (4 shared papers)Wayne C. Guida (4 shared papers)Harshani R. Lawrence (4 shared papers)Saı̈d M. Sebti (4 shared papers)James Turkson (3 shared papers)Khandaker Siddiquee (1 shared paper)Michelle A. Blaskovich (1 shared paper)Shumin Zhang (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Oncology (1 paper)Molecular Cancer Therapeutics (1 paper)Journal of Natural Products (1 paper)
- Partner nations
- United StatesAustraliaHong Kong
In The Last Decade
M.L. Richard Yip
15 papers receiving 1.4k citations
M.L. Richard Yip's Hit Papers
Peers
Comparison fields: 5 of 98
- Toxicology 89
- Oncology 576
- Immunology 337
- Molecular Biology 801
- Cancer Research 116
Countries citing papers authored by M.L. Richard Yip
This map shows the geographic impact of M.L. Richard Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Richard Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Richard Yip more than expected).
Fields of papers citing papers by M.L. Richard Yip
This network shows the impact of papers produced by M.L. Richard Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Richard Yip. The network helps show where M.L. Richard Yip may publish in the future.
Co-authors
The 25 scholars most cited alongside M.L. Richard Yip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Hit paper breakdown → | 2007 | 637 |
| 2 | 2006 | 240 | |
| 3 | 1997 | 87 | |
| 4 | 2008 | 85 | |
| 5 | 2014 | 76 | |
| 6 | 2013 | 67 | |
| 7 | 2012 | 65 | |
| 8 | 2012 | 60 | |
| 9 | 2015 | 26 | |
| 10 | 2009 | 23 | |
| 11 | 2015 | 23 | |
| 12 | 2015 | 20 | |
| 13 | 2011 | 15 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 6 |
About M.L. Richard Yip
M.L. Richard Yip is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Immunology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (3 papers), Galectins and Cancer Biology (2 papers), Phytochemistry and Biological Activities (2 papers), Flavonoids in Medical Research (2 papers), Chemokine receptors and signaling (2 papers), Protein Tyrosine Phosphatases (2 papers), Marine Sponges and Natural Products (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Toxicology (89 citations), Oncology (576 citations), Immunology (337 citations), Molecular Biology (801 citations) and Cancer Research (116 citations). M.L. Richard Yip has collaborated with scholars based in United States, Australia and Hong Kong. Frequent co-authors include Nicholas J. Lawrence, Wayne C. Guida, Harshani R. Lawrence, Saı̈d M. Sebti, James Turkson, Khandaker Siddiquee, Michelle A. Blaskovich, Shumin Zhang, Richard Jove and Benjamin Greedy. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences, Molecular Oncology, Molecular Cancer Therapeutics and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.